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Background Information
Electrophysiologic changes with aging. Age-related
changes in the specialized conducting system frequently
produce serious disturbances of conduction and impulse for-
mation. Although no single abnormality is confined to a
specific age, the sick sinus syndrome and trifascicular block
can be viewed as predominantly geriatric diseases. The in-
cidence of supraventricular and ventricular premature com-
plexes and rhythms increases with age (1-3). In a recent
study (3) of 50 subjects > 80 years old with no evidence of
heart disease; supraventricular ectopic complexes were pres-
ent in all and ventricular premature complexes in 96% . The
increase of ventricular arrhythmias occurring in men is ex-
ponential from age 16 to 74 (4).
Pathology (5-8). Specific for old age are: 1) Fibrosis
of the sinoatrial node with concomitant decrease of the num-
ber of pacemaker cells. In very old persons, the fibrous
tissue proliferates to such an extent that the pacemaker cells
form small islands within the collagen mass, and histologic
examination often discloses no connections between the
scattered nodal cells and the atrial myocardium. 2) Degen-
eration and fibrosis of the central fibrous body and summit
of the ventricular septum. The increased fibrosis of old age
may produce an apparent atrophy of the conducting tissue,
and the atrionodal connections may become disrupted by
the connective and adipose tissues. 3) Fibrosis and calci-
fication of the mitral and aortic valve rings and leaflets.
Less specific findings are: increased prevalence of coro-
nary atherosclerosis, ventricular hypertrophy, atrial dilation,
myocardial fibrosis and lipofuscin as well as amyloid de-
posits. Myocardial fibers themselves show no distinct gross
or microscopic age-related abnormalities.
Electrocardiogram (ECG). The prevalence of brady-
cardia is increased as a result of both impaired sinoatrial
node function and altered autonomic tone (9). The QRS
electrical axis tends to shift leftward with age because of
changes in heart position and subtle changes in intraven-
tricular conduction (10). Also, the incidence of overt intra-
ventricular conduction disturbances (except for left posterior
fascicular block) increases with age (10-12). Conduction
through the atrioventricular (AV) node slows with age, but
the slowing seldom reaches a level of clinical significance.
In various series, about 10% of the elderly had evidence of
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fascicular block (10-12) . There is an increased prevalence
of nonspecific T wave abnormalities; abnormal ECG pat-
terns caused by hypertension, coronary artery disease, aortic
stenosis and chronic obstructive lung disease are also more
common.
Symptoms. The symptoms caused by arrhythmias and
conduction disturbances in the elderly are the same as those
in any other age group, that is, palpitation, increasing se-
verity of angina pectoris, congestive heart failure, presyn-
copal sensations, syncope and cardiac death. Of these, pre-
syncope and syncope of cardiac causes appear to correlate
best with aging and are responsible for some falls that cause
injuries and fractures in the elderly population (13,14). The
increased incidence of syncope is due, in part, to the in-
creased prevalence of symptomatic sick sinus syndrome,
fascicular blocks and ventricular tachyarrhythrnias. How-
ever, even less drastic abnormalities of rate and rhythm can
be of consequence when added to other factors contributing
10 the critical decrease in cerebral blood flow. Therefore,
the arrhythmias causing syncope in the elderly must be
discussed in the context of the general pathophysiology of
syncope in this age group.
Syncope in the Elderly
Syncope is a common clinical condition that may occur
in up to 30 to 50% of presumably healthy adults. In the
elderly, the incidence of syncope appears to be increased.
In one study of 711 very old persons (average age 87 years),
the incidence was 7%/year (15). In these patients, the etiol-
ogy was cardiac in 21%, noncardiac in 48% and unexplained
in 31%.
The elderly are more susceptible to syncope because
cerebral blood flow decreases with aging . Because cerebral
blood flow is reduced in the elderly, syncope may be the
firsl manifestation of many serious illnesses. Common age-
related conditions associated with syncope include: l) cere-
brovascular atherosclerosis; 2) calcific aortic stenosis; 3)
obstructive cardiomyopathy; 4) pulmonary embolism (syn-
cope is an initial symptom in 13%) (16); 5) acute volume
depletion, for example, due to bleeding, diuresis or dehy-
dration; 6) hypotension due to orthostasis, varicose veins,
anemia or hyponatremia; 7) postprandial blood pressuredrop;
8) autonomic insufficiency, for example, in diabetes; 9) use
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of predisposing drugs, for example, beta-adrenergic block-
ing agents, vasodilators, calcium blockers, antihypertensive
agents or lithium; and 10) sick sinus syndrome. tachycardia-
bradycardia syndrome, intraventricular conduction distur-
bances, supraventricular tachyarrhythmias and ventricular
tachyarrhythmias.
Differentiation from transient ischemic attack. As a
rule, the symptoms of transient ischemic attack are distinctly
different from syncope. Adams-Stokes attacks produce no
focal neurologic symptoms. Of 290 patients who received
a permanent cardiac pacemaker at the Mayo Clinic (17) .
only 4 had focal neurologic symptoms. Conversely . syncope
is uncommon in patients with cerebral ischemia due to cere-
brovascular disease. In one study of 557 ischemic events
(18), only 31 events (6.5%) were associated with transient
loss of consciousness and they occurred more often with
embolic stroke than with thrombosis or transient ischemic
attacks.
Sick Sinus Syndrome
Sick sinus syndrome refers to a spectrum of abnormalities
of sinus node and atrial function that have been classified
into three major groups: group 1. persistent, unexplained
sinus bradycardia; group 2. intermittent or sustained sinus
arrest; and group 3, the bradycardia-tachycardia syndrome
characterized by the presence of group I or group 2 in
association with episodes of paroxysmal atrial tachyarrhyth-
rnias. Sinus node dysfunction is often accompanied by im-
paired automaticity and conduction in the AV conduction
system (19) . Many individuals with sinus node dysfunction
remain asymptomatic. When symptoms occur. they are most
commonly disturbances of consciousness (dizziness, pre-
syncope or syncope) due to bradyarrhythmias. Less COm-
monly, patients present with palpitation, fatigue. exacer-
bation of angina or congestive heart failure or sequelae of
thromboembolism.
Symptom-arrhythmia correlation. The asymptomatic
subject with sick sinus syndrome requires no treatment. This
may also be true for subjects with brief sporadic episodes
of palpitation or dizziness. In patients with more frequent
or marked symptoms, such as syncope. it is imperative to
be certain that the rhythm disturbance and clinical symptoms
arc correlated. This is particularly important in the elderly.
in whom both sinus bradycardia and syncope are extremely
common and usually unrelated. Of the available diagnostic
techniques, ambulatory ECG recording is the most useful
in correlating symptoms with spontaneous arrhythmias (20).
However , in patients with sporadic and infrequent symp-
toms, a definitive diagnosis is frequently unobtainable .
Invasive electrophyslologic testing is neither highly sen-
sitive nor specific when applied to the sick sinus syndrome
and, except in the rare subject in whom symptoms are re-
produced during testing, adds little to the noninvasive eval-
uation. Drugs that can cause bradycardia should be avoided
in any patient with symptomatic sinus node dysfunction.
Therapy. Pacemaker therapy is effective in treating syn-
cope that occurs in association with the sick sinus syndrome.
In patients who do not have chronic atrial fibrillation, dual
chamber pacing may be associated with a more favorable
hemodynamic response than ventricular-inhibited pacing mode
(VVI) pacing. In some patients, dual chamber pacing may
contribute to the prevention of paroxysmal atrial flutter and
fi brillation. Both antiarrhythmic drugs for the prevention of
symptomatic atrial tachyarrhythmias and pacing for brady-
cardia may be required (21). Patients with the bradycardia-
tachycardia syndrome are at increased risk for systemic
embolism and many physicians recommend long-term pro-
phylactic anticoagulant therapy for these patients unless
paroxysmal tachyarrhythmias are effectively suppressed
with antiarrhythmic drugs (22).
Carotid Sinus Hypersensiti vity
Carotid sinus hypersensitivity appears to increase with
aging (23 ,24) . Typical symptoms are related to turning of
the head or stretching the neck. Carotid sinus massage is
most frequently used to establish the diagnosis. This pro-
cedure should be avoided in patients with carotid bruits or
symptomatic cerebrovascular disease. Syncope occurs in
only about one-third of persons with a hypersensitive carotid
sinus; the association is termed "carotid sinus syndrome"
(25.26). Using stringent criteria, Morley et al. (27) esti-
mated that the incidence of the syndrome in the elderly in
one region in Great Britain was 82imillion population per
year.
Unexplain ed Syncope
The two main reasons for unexplained syncope after a
thorough noninvasive evaluation arc: 1) it is a nonrecurring
event. even in the absence of treatment, and 2) it has a
pluricausal etiology. frequently accompanied by polyphar-
macy.
Ambulatory fCC in Diagnosis
Normal findings in the elderly. Ambulatory ECG is
widely used in the diagnosis and management of patients
with cardiac arrhythmias and unexplained central nervous
system symptoms such as dizziness and syncope. To eval-
uate the ambulatory ECG data, it is important to establish
a range of " normal" findings in an elderly population free
of clinical evidence of heart disease. In a study by Fleg and
Kennedy (2), 98 healthy subjects, aged 60 to 85 years, had
24 hour ambulatory ECGs and in another study (3) 50 sub-
jects over the age of 80 had ambulatory ECGs evaluated
(Table I). Of note is a substantial incidence of asymptomatic
supraventricular as well as ventricular arrhythmias in this
healthy elderly population (2). Thus. one should be cautious
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Table I. Ambulatory ECG Findings in Elderly Subjects With
No Clinical Heart Disease
Electrophysiologic Testing
The major indication for electrophysiologicstudies in the
evaluation of syncope is the presence of unexplained and
in ascribing syncope to asymptomatic tachyarrhythmias in
ambulatory ECG recordings of elderly patients with syn-
cope.
Diagnostic yield. The yield of ambulatory ECG to aid
in the diagnosis of syncope depends on the type of popu-
lation studied. In patients with frequent symptoms, ambu-
latory ECG explains syncope in about 10% of cases, and
in an additional 10% it provides suggestive evidence of its
cause. The diagnostic yield of ambulatory ECG is less in
patients with infrequent symptoms. In a study (28) of 1,512
patients referred for evaluation of syncope, this symptom
occurred during ambulatory ECG in 15(I %) and was related
to arrhythmias in 7 of 15. Presyncope was reported in 241
patients, with a related arrhythmia in 24. Syncope was most
commonly related to ventricular tachycardia (three of seven).
Other causes, one each, included sinus bradycardia, AV
block. supraventricular tachycardia and atrial fibrillation .
Presyncope was most often associated with supraventricular
arrhythmias (24 patients) including supraventricular tachy-
cardia in 9, sinus tachycardia in 7, atrial fibrillation in I
and atrial premature complexes in I; presyncope was related
to slow heart rate, including AV block, in the others. An
arrhythmia-related symptom that could be diagnostic was
present in only 2% of patients with syncope. A negative
correlation, in which symptoms were documented without
related arrhythmias, may be potentially diagnostic and oc-
curred in 15% of these patients (28).
The diagnostic yield of ambulatory ECG recordings for
the diagnosis of unexplained syncope may be higher in pa-
tients with heart disease, especially in the presence of ab-
normalities on the ECG at rest such as bradycardia, first
degree AV block. bundle branch block or an intraventricular
conduction defect. Generally, 48 hours of ambulatory ECG
is done under these circumstances, although the increased
diagnostic information obtained from the second 24 hour
recording is not known. In patients with infrequentepisodes
of presyncope, either alone or associated with syncope, a
patient-activated event recorder may assist in diagnosis.
Heart rate (beats/min)
Longest sinus pauses (seconds)
Supraventricular premature complexes (> 20!h) (% )
Paroxysmal supraventricular tachycardia (% )
Ventricular premature complexes (> In/h) (%)
Ventricular couplets (%1
Ventricular tachycardia (%)
Data from Fleg and Kennedy (2) and Kantelip et al. (3) .
3410 180
1.8 to 2
66
13 to 28
32
8 to II
2 to 4
recurrent syncope, especially in a patient with a disorder in
which a cardiac cause of syncope is likely; such disorders
include bifascicular block, alternating bundle branch block,
second degree or high grade AV block, wide QRS tachy-
cardia, pre-excitation syndrome, left ventricular aneurysm
and coronary artery disease with or without prior myocardial
infarction. Doherty et al. (29) found that structural heart
disease and a previous myocardial infarction were predictive
of a positive response to electrophysiologic testing. Com-
bined results in five studies of 260 patients from different
centers show an incidence of supraventricular tachycardia
in I to 24%. transient ventricular tachycardia in 21%, and
sustained ventricular tachycardia in 12 to 17% of patients.
It has been suggested (30) that only the induction of sus-
tained ventriculartachycardia (but not polymorphic transient
ventricular tachycardia or ventricular fibrillation) is predic-
tive of the recurrence of syncope. Also, a negative electro-
physiologic study may be of some value because 70% of
patients with a negative study and no treatment had no
recurrence. This procedure is much less useful in docu-
menting suspected sick sinus syndrome as a cause of syn-
cope. Normal AV intervals do not exclude intermittent AV
block as a cause of syncope.
Prognosis of Syncope
Prognosis is related to the severity of the heart disease.
In patients with cardiovascular syncope, the I year mortality
rate was 24%. in patients with noncardiovascular syncope,
it was 2 to 4% and in those with syncope of unknown cause
it was 3% (31). In the Framingham study only two deaths
occurred in subjects with noncardiac syncope, and during
26 years of follow-up of isolated syncope, there was no
association with any excess of stroke, transient ischemic
attacks, myocardial infarction, total mortalityor sudden car-
diac death. Sinus bradycardia, sick sinus syndrome and right
bundle branch block had no independenteffect on prognosis.
In the Framingham study, left bundle branch block was
associated with a worse prognosis in subjects with a preex-
isting ECG abnormality or a superior QRS axis (32).
Treatment of Syncope
In the patient with severe aortic stenosis . aortic valve
replacement frequently cures syncope and increases life ex-
pectancy.
Treatment of ventricular tachvarrhythmias with drugs
may be effective even if the drug docs not suppress the
arrhythmia but slows the rate of ventricular tachycardia.
because syncope is related to the rate of ventricular tachy-
cardia.
Treatment of the carotid sinus syndrome may not be
needed if the symptoms are limited to presyncopal sensa-
tions. Even a single syncopal episode may be a nonrecurrent
event. For vasodepressorcarotid sinus syncope (23), options
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for therapy include carotid sinus irradiation or administra-
tion of mineralocorticoids.
Pacemaker therapy. Permanent pacing is indicated in
patients with syncope or near syncope who have second
degree or complete AV block. as well as in patients who
have the sicksinus syndromewithdocumentedsymptomatic
bradycardia. It is also indicated in patients with a hyper-
sensitive carotid sinus syndrome who have repeated symp-
toms and whose syndrome is of the cardioinhibitory type
(21). A ventricular demand pacemaker or a pacemaker that
responds with increasingrate to activity or other physiologic
variables is indicated in patients who have atrial fibrillation
with symptomatic bradycardia.
In other patients, particularly patients with brady-
arrhythmias, there is an increased trend toward insertion of
a dual-chamberpacemaker(DOD). This pacemakerpermits
normal AV sequence and a cardiac rate proportionate to
activity needs. Stimulation of the atrium is helpful in pre-
venting atrial arrhythmias. Restoration of the normal AV
sequence is especially important for those bradyarrhythmias
with intact retrograde conduction. This is the case in about
one-half of the patients with sinus node dysfunction. Ven-
tricular stimulation alone in this situation may reverse the
normal AV sequence and cause a decrease in cardiac output
and an increase in pulmonary venous pressure, a complex
called the pacemaker syndrome. This may cause disabling
symptoms, such as fatigue, light-headedness and near syn-
cope, as well as congestive heart failure. ln patients with
decreased left ventricular compliance, normal AV sequence
may improve left ventricularfilling and thus enhancecardiac
output.
Disadvantages ofthe DDD pacemaker are the moderately
higher initial cost of the unit and the need for increased
technologic skill of the physician to properly implant the
atrial lead and appropriately monitor and adjust the pace-
maker. In addition, the expected life of the generator is
shorter. DOD pacemakers are used mostly for patients who
are ambulatory and physically active. whereas ventricular-
inhibited (VVI) pacemakers are generally reserved for pa-
tients who have a shorter anticipated life span and who are
sedentary or bedridden.
Pacemakers are extremely important in prolonging life
and improving quality of life in the geriatric population .
They not only treat the bradycardias but may abolish brady-
cardia-related ventricular tachycardia or ventricular fibril -
lation that, in different series, precipitates from 15 to 60%
of Adams-Stokes attacks in patients with AV block.
Ventricular Arrhythmias
Indications for treatment of ventricular arrhythmias.
At present there are insufficient data to define the prognostic
significance of complex ventricular ectopic activity in ap-
parently healthy elderly subjects. Ventricular premature
complexes recorded on a single ECU were not predictive
of increased risk of death during a 5 year follow-up in a
large elderly population (12). Observations (33) in subjects
in a broader age range suggest that even complex ventricular
ectopic activity, when asymptomatic and present in subjects
without clinically demonstrable heart disease, is associated
with an excellent prognosis in the absence of antiarrhythmic
therapy. Also. there is no evidence that antiarrhythmic drug
therapy for treatment of ventricular ectopic activity in an
asymptomatic elderly person is useful; in fact, it may be
harmful because the antiarrhythmic drug may cause or worsen
ventricular arrhythmias.
Therapy of ventricular arrhythmias. Three aspects
must be considered when it is necessary to use antiarrhyth-
mic drug therapy in the elderly. The first is that the phar-
macokinetics of these drugs differ considerably in older as
compared with younger subjects. The second is that the
elderly patient is likely to be taking several concomitant
medications that may cause manifold drug interactions with
antiarrhythmic drugs. The third is that there are dynamic
interactions of antiarrhythmic drugs with morphologic or
physiologic alterations in the elderly.
Drug Therapy of Arrhythmias
Pharmacokinetics of antiarrhythmic drugs in the el-
derly. With few exceptions, it can be anticipated that anti-
arrhythmic drugs will have a longer elimination half-life in
the elderly because of their decreased rate of renal excretion
or hepatic metabolism, or both (Table 2).
Interaction of antiarrhythmic drugs with other car-
diovascular agents. The large number of drugs frequently
prescribed to elderly patients concomitantly with antiar-
rhythmic agents requires that the physician be familiar with
the interactions of these drugs. Some of the best studied
drug interactions include those between digoxin and quin-
idine (increased digoxin levels with concomitant quinidine
therapy) and increased digoxin levels with amiodarone or
verapamil (34). The concurrent administration of cimetidine
has been shown to decrease the elimination half-life of both
procainamide and quinidine (35,36). Phenytoin may in-
crease the metabolism of quinidine by inducing hepatic mi-
crosomal enzymes, resulting in a decrease of the plasma
concentration of quinidine, an interaction that can be clin-
ically important (37,38). Nifedipine administered concom-
itantly with quinidine may significantly decrease the serum
concentrations of quinidine and reduce its antiarrhythmic
effect (39.40). In contrast, increased quinidine plasma COD-
centrations have been reported with the concomitant usc of
verapamil , due to a decrease in quinidine clearance (41).
Altered responsiveness of the heart to antiarrhythmic
drugs with aging. There is a paucity of data on possible
altered responsiveness to antiarrhythmic drugs in the el-
derly. There is a diminished responsiveness of the beta-
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Table 2. Alteration s in Pharmacokineti cs of Antiarrhythmic Drugs in the Elderly
Antiarrhythmic Drug
Quinidine
Procainarnidc
(Pronestyl)
(Prones tyl-S k)
(Procan-Sk)
Disopyramide
(Norpace)
(Norpace-Sk)
Cibenzoline"
Lidocaine
(Xylocaine)
Tocainide
(Tonocard)
Phenytoin
(Dilantin)
Propranolol
(Inderal)
Sotalol*
Verapamil
(e,llan)
(Isoptin)
Digoxin
(La noxin)
(Lanoxicaps)
Metabolic Alteration
With Aging
Decreased clearance
Decrease in renal filtration and tubular secretion of procainamide:
increase in NAPA/PA serum ratio
No data in rhe elderly; with decreased renal function. there is a
decrease in renal clearance of disopyramide but no change in
elimination half-life
Increased elimination half-life; decrease in volume of distribution.
decrease in renal and nonrenal clearance with agc
Decreased clearance with age
No data in the elderly; 40% excreted unchanged in the urine; therefore,
elimination half-life should be increased in the elderly
Decrease in hepatic metabolism; increase in serum concentration at
comparable doses
Increased plasma levels due to depressed rate of hepatic metabolism
Increased elimination half-life due to decreased rate of renal elimination
Increased elimination half-life due to decreased liver blood now
Decrease in renal clearance as well as volume of distribution; increase
in elimination half-life
First Author
and Reference
Drayer (43.44)
Reidenbcrg (45)
Burk (461
Brazzell (47)
Drayer (411)
Bauer (4<1)
Castleden (50)
Ishizaki (51 )
Freedman (521
Ewy (53), Cusack (54)
"NOl approved for clinical use in the United States. NAPA = N-acetyl procainarnide; PA = procainarnide.
adrenoreceptor to both isoproterenol and propranolol in the
elderly (see Medical Therapy in the Elderly) .
Dynamic interactions of antiarrhythmic drugs with
morphologic or physiologic alterations. Elderly patients
are likely to have an increased prevalence of various mor-
phologic changes that may be exacerbated by antiarrhythmic
drug therapy _For example, the sick sinus syndrome, present
predominantly in the elderly, may be worsened by most
antiarrhythmic drugs. Cardiac failure may be precipitated
by disopyramide, Ilecainide or propafenone, particularly in
patients with previous myocardial infarction or decreased
myocardial reserve due to age or valvular heart disease , or
both . AV conduction disturbances may worsen in patients
with preexisting AV conduction delay s who are treated with
antiarrhythmic drugs. Also, bundle branch block may be
induced by antiarrhythmic drugs such as flecainide and en-
cain ide in patients who have a minor preexisting intraven-
tricular conduction defect.
Anticoagulant Therapy for Patients
With Atrial Fibrillation
The relation between atrial fibrillation associated with
rheumatic mitral stenosis and embolism has long been known;
however, it has only recently been appreciated that, in the
absence of valvular lesions, atrial fibrillation is an important
risk factor for embolic stroke . Thi s latter category of atrial
fibrillation occurs in 2 to 5% of the general population > 60
years (42), but it is not known whether chronic anticoag-
ulation decreases the risk of embolism in this subset. Con-
founding variables regarding the occurrence and character
of stroke include the frequent prevalence of atherosclerotic
heart disease and hypertensive cardiovascular disease in this
population and the difficulty in differentiating between em-
bolic and thrombotic stroke.
The risk-benefit ratio of anticoagulation in the elderly
has not been established. Brain hemorrhage may occur in
I% yearly (eightfold increased risk) and major hemorrhage
in other organs in 3% yearly of patients using conventional
anticoagulant therapy. The greatest risk of embolism ap-
pears to be in the initial months after the onset of atrial
fibrillation, particularly if there is associated congestive heart
failure, and if the patient has had prior embolism. Rec-
ommendations Ior routine use of chronic anticoagulation in
the elderly patient with atrial fibrillation in the absence of
valvular disease must await the results of ongoing clinical
trials .
Pacemaker Therapy of Arrhythmias
These recommendations are covered in the preceding
section on Treatment of Syncope,
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